Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 495 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Meda Dymista now available on prescription in UK

Dymista is indicated for the symptomatic treatment of moderate to severe seasonal and perennial allergic rhinitis if monotherapy with either intranasal antihistamine or glucocortocoid is not considered sufficient.

FDA approves Aurobindo Cefadroxil antibiotic

The approval will allow the company to manufacture and market the generic equivalent of Warner Chilcott Company’s Durice for Oral Suspension 250mg/5mL and 500mg/5mL. Cephalosporin antibiotic is indicated

Porkka launches new scientific product range

The company has launched new incubators, which can be adjusted between +4 to +60°C, to grow cultures or pathogens in a controlled temperature environment. Porkka has also introduced

Covaris introduces new AFA-based processing system

The FS220-M system, which extends the company’s adaptive focused acoustics (AFA) technology platform, can process sample volumes ranging from microliters to liters with a continuous flow process. Covaris